AbFUSE: Joint Antibody Optimization for Discriminating Similar Targets
Abstract
Advances in protein structure prediction enable model-guided antibody sequence optimization, yet suppressing binding to related negative targets can also reduce predicted binding to the intended target. We present AbFUSE, a training-free framework that optimizes one antibody sequence against a positive target and multiple negative targets using frozen structure and affinity predictors. A reference-score penalty limits decreases in predicted positive-target binding; an optional static local relation term compares mapped target neighborhoods. For chimeric antigen receptor (CAR) design, the objective can additionally include a sequence-level positively charged patch (PCP) term from CAR-Tonic Signal Tuner (CAR-Toner). We evaluate candidate quality on a computational benchmark and explore multi-target predictions in a case study involving STEAP family members. No updated AbFUSE benchmark candidate passed the prespecified interface-confidence gate. In an exploratory AlphaFold Server assessment, designs targeting STEAP family member 1 (STEAP1) showed lower predicted binder–target pairwise alignment error against STEAP1 than against STEAP2/3; this pattern also appeared in the baseline designs. These findings characterize the framework and its current validation limits without establishing experimental affinity or selectivity.
Then back it, or bet against it.
Related papers
Open the market on this paper to see 7 more related papers.